|
|
|
Insider
Information: |
Aryeh Jason |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
401,047 |
|
Indirect Shares
|
890,847 |
|
|
Direct
Value |
$7,148,144 |
|
|
Indirect Value
|
$4,945,268 |
|
|
Total
Shares |
1,291,894 |
|
|
Total
Value |
$12,093,412 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VXRT |
Vaxart Inc |
Director |
|
2010-10-11 |
4 |
S |
$5.00 |
$22,110 |
I/I |
(4,422) |
244,456 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-03-13 |
4 |
B |
$112.51 |
$22,727 |
I/I |
202 |
51,594 |
2.1 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2012-05-31 |
4 |
B |
$2.35 |
$23,771 |
I/I |
10,133 |
536,104 |
2.1 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2012-06-16 |
4 |
OE |
$10.00 |
$25,000 |
I/I |
2,500 |
153,578 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-14 |
4 |
B |
$2.64 |
$25,608 |
I/I |
9,700 |
81,266 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-11-18 |
4 |
S |
$5.24 |
$25,676 |
I/I |
(4,900) |
196,483 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-30 |
4 |
B |
$2.61 |
$25,790 |
I/I |
9,900 |
9,900 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-12-08 |
4 |
S |
$5.49 |
$25,830 |
I/I |
(4,705) |
181,783 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-11-11 |
4 |
S |
$5.30 |
$25,970 |
I/I |
(4,900) |
201,383 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-07-29 |
4 |
AB |
$106.01 |
$26,503 |
D/D |
250 |
61,953 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-06-11 |
4 |
AB |
$107.01 |
$26,753 |
D/D |
250 |
61,703 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-05-30 |
4 |
AB |
$110.01 |
$27,503 |
D/D |
250 |
60,118 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-05-29 |
4 |
AB |
$111.01 |
$27,753 |
D/D |
250 |
59,868 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-05-20 |
4 |
AB |
$112.01 |
$28,003 |
D/D |
250 |
59,618 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-05-14 |
4 |
AB |
$112.51 |
$28,128 |
D/D |
250 |
59,368 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2011-03-15 |
4 |
S |
$5.87 |
$28,763 |
I/I |
(4,900) |
131,783 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2012-05-21 |
4 |
B |
$2.51 |
$30,060 |
I/I |
12,000 |
520,536 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2007-05-30 |
4 |
B |
$6.48 |
$32,400 |
D/D |
5,000 |
29,700 |
2.39 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-11-09 |
4 |
S |
$5.26 |
$33,677 |
I/I |
(6,400) |
217,483 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-14 |
4 |
B |
$9.59 |
$33,900 |
I/I |
3,500 |
271,111 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-12-01 |
4 |
S |
$5.53 |
$37,051 |
I/I |
(6,700) |
186,488 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-16 |
4 |
B |
$9.25 |
$37,405 |
I/I |
4,000 |
276,611 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-03-18 |
4 |
S |
$5.96 |
$39,225 |
I/I |
(6,581) |
352,620 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-11 |
4 |
B |
$9.75 |
$39,355 |
I/I |
4,000 |
3,025 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2009-12-22 |
4 |
S |
$5.24 |
$42,103 |
I/I |
(8,035) |
779,385 |
0 |
- |
|
175 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|